Jaumot Frank E
SEC Form 4 insider trading activity
Jaumot Frank E has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 3, 2026.
On the most recent filing, Jaumot Frank E is listed as Director at Nutex Health Inc. Inside the rolling window, Jaumot Frank E reported 1 open-market purchase totaling $14K in NUTX and no open-market sales.
Companies traded
Other insiders at NUTX
Insider Buying
$14K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Jaumot Frank E made?
Jaumot Frank E has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Jaumot Frank E trade?
Jaumot Frank E has filed SEC Form 4 disclosures for 1 company, including NUTX.
When was Jaumot Frank E's most recent SEC Form 4 filing?
Jaumot Frank E's most recent SEC Form 4 filing on Tracefour is dated Aug 3, 2026.
What is Jaumot Frank E's total buy and sell value in the current window?
Inside the rolling retention window, Jaumot Frank E bought $14K and sold $0 based on SEC Form 4 filings.
What was Jaumot Frank E's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 150 NUTX shares on 2026-03-20, worth $14K, per SEC Form 4 filings.